Lack of GNAQ and GNA11 germ-line mutations in familial melanoma pedigrees with uveal melanoma or blue nevi

Frontiers in Oncology

Volumn 3 JUN, Issue , 2013, Pages

  Hawkes, Jason E ^a   Campbell, Jennifer ^a   Garvin, Daniel ^a   Cannon Albright, Lisa ^b   Cassidy, Pamela ^a   Leachman, Sancy A ^a,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Blue nevi; Familial melanoma; Germ line; GNA11; GNAQ; Uveal melanoma

Indexed keywords

B RAF KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT 11; MITOGEN ACTIVATED PROTEIN KINASE; N RAS PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CLINICAL ARTICLE; CUTANEOUS MELANOMA; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MELANOMA; MUTATION; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TUMOR GROWTH; UVEA MELANOMA;

EID: 84891642432     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00160     Document Type: Article

References (17)

1. Abdel-Rahman, M. H., Pilarski, R., Cebulla, C. M., Massengill, J. B., Christopher, B. N., Boru, G., et al. (2011). Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet. 48, 856-859. doi:10.1136/jmedgenet-2011-100156.
2. Amos, C. I., Wang, L. E., Lee, J. E., Gershenwald, J. E., Chen, W. V., Fang, S., et al. (2011). Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum. Mol. Genet. 20, 5012-5023. doi:10.1093/hmg/ddr415.
3. Dong, Q., Shenker, A., Way, J., Haddad, B. R., Lin, K., Hughes, M. R., et al. (1995). Molecular cloning of human G alpha q cDNA and chromosomal localization of the G alpha q gene (GNAQ) and a processed pseudogene. Genomics 30, 470-475. doi:10.1006/geno.1995.1267.
4. Eliason, M. J., Larson, A. A., Florell, S. R., Zone, J. J., Cannon-Albright, L. A., Samlowski, W. E., et al. (2006). Population-based prevalence of CDKN2A mutations in Utah melanoma families. J. Invest. Dermatol. 126, 660-666. doi:10.1038/sj.jid.5700094.
5. Goldstein, A. M., and Tucker, M. A. (2001). Genetic epidemiology of cutaneous melanoma. Arch. Dermatol. 137, 1493-1496.
6. Harbour, J. W. (2012). The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res. 25, 171-181. doi:10.1111/j.1755-148X.2012.00979.x.
7. Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., et al. (2010). Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410-1413. doi:10.1126/science.1194472.
8. Hayward, N. K. (2003). Genetics of melanoma predisposition. Oncogene 22, 3053-3062. doi:10.1038/sj.onc.1206445.
9. Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., et al. (2009). Selection criteria for genetic assessment of patients with familial melanoma. J. Am. Acad. Dermatol. 61, 677.e1-e14. doi:10.1016/j.jaad.2009.03.016.
10. Onken, M. D., Worley, L. A., Long, M. D., Duan, S., Council, M. L., Bowcock, A. M., et al. (2008). Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 49, 5230-5234. doi:10.1167/iovs.08-2145.
11. Saldanha, G., Purnell, D., Fletcher, A., Potter, L., Gillies, A., and Pringle, J. H. (2004). High BRAF mutation frequency does not characterize all melanocytic tumor types. Int. J. Cancer 111, 705-710. doi:10.1002/ijc.20325.
12. Shin, M. K., Levorse, J. M., Ingram, R. S., and Tilghman, S. M. (1999). The temporal requirement for endothelin receptor-B signalling during neural crest development. Nature 402, 496-501. doi:10.1038/990040.
13. Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., et al. (2011). Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022-1025. doi:10.1038/ng.912.
14. Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O'Brien, J. M., et al. (2008). Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602. doi:10.1038/nature07586.
15. Van Raamsdonk, C. D., Fitch, K. R., Fuchs, H., De Angelis, M. H., and Barsh, G. S. (2004). Effects of G-protein mutations on skin color. Nat. Genet. 36, 961-968. doi:10.1038/ng1412.
16. Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., et al. (2010). Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191-2199. doi:10.1056/NEJMoa1000584.
17. Wadt, K., Choi, J., Chung, J.-Y., Kiilgaard, J., Heegaard, S., Drzewiecki, K. T., et al. (2012). A crypticBAP1splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res. 25, 815-818. doi:10.1111/pcmr.12006.